CDC 57.115 Central Line Insertion Practices Adherence Monitoring (r

[NCEZID] The National Healthcare Safety Network (NHSN)

57.125_CLIP_November_2022

57.125 Central Line Insertion Practices Adherence Monitoring Form

OMB: 0920-0666

Document [docx]
Download: docx | pdf

Form Approved

OMB No.

Exp. Date:

www.cdc.gov/nhsn

Central Line Insertion Practices Adherence Monitoring

Page 1 of 2

*required for saving

Facility ID: _____________________

Event #: ________________________________

*Patient ID: _____________________

Social Security #: __ __ __ - __ __ - __ __ __ __

Secondary ID: ____________________

Medicare #: _______________________

Patient Name, Last: _____________________

First: __________________

Middle: __________________

*Gender: F M Other

*Date of Birth: ___ /___ /______ (mm/dd/yyyy)

Sex at Birth: F M Unknown

Gender Identity (specify):________________________

Ethnicity (specify): ____________________________

Race (specify): ________________________________

*Event Type: CLIP

*Location: ________________________

*Date of Insertion: ___ /___ /_____ (mm/dd/yyyy)

*Person recording insertion practice data:

Inserter

Observer

Central line inserter ID: _________

Name, Last: ____________________

First: ______________________

*Occupation of inserter:

Fellow

Medical student

Other student

Other medical staff

Physician assistant

Attending physician

Intern/resident

Registered nurse

Advanced practice nurse

Other (specify): ______________________

*Was inserter a member of PICC/IV Team?

Y

N

*Reason for insertion:

New indication for central line (e.g., hemodynamic monitoring, fluid/medication administration, etc.)

Replace malfunctioning central line

Suspected central line-associated infection

Other (specify): ________________________

If Suspected central line-associated infection, was the central line exchanged over a guidewire? Y N

*Inserter performed hand hygiene prior to central line insertion:

Y

N

(if not observed directly, ask inserter)

*Were all 5 maximal sterile barriers used?

Y N



*Maximal sterile barriers used:

Mask Y N

Sterile gown Y N



Large sterile drape Y N

Sterile gloves Y N

Cap Y N

*Skin preparation (check all that apply)

Chlorhexidine gluconate

Povidone iodine

Alcohol


Other (specify): _____________________

If skin prep choice was not chlorhexidine, was there a contraindication to chlorhexidine?

Y

N

U

If there was a contraindication to chlorhexidine, indicate the type of contraindication:

Patient is less than 2 months of age - chlorhexidine is to be used with caution in patients less than 2 months of age

Patient has a documented/known allergy/reaction to CHG based products that would preclude its use

Facility restrictions or safety concerns for CHG use in premature infants precludes its use

*Was skin prep agent completely dry at time of first skin puncture?

Y

N

(if not observed directly, ask inserter)

*Insertion site:

Femoral

Jugular

Lower extremity

Scalp

Subclavian

Umbilical

Upper extremity

Antimicrobial coated catheter used:

Y

N

Assurance of Confidentiality: The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)).


Public reporting burden of this collection of information is estimated to average 25 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS D-74, Atlanta, GA 30333, ATTN: PRA (0920-0666).

CDC 57.125 (Front)

Central Line Insertion Practices Adherence Monitoring

Page 2 of 2

*Central line catheter type:

Non-tunneled (other than dialysis)

PICC

Tunneled (other than dialysis)

Umbilical

Dialysis non-tunneled

Other (specify): _______________________________

Dialysis tunneled

(“Other” should not specify brand names or number of lumens; most lines can be categorized accurately by selecting from options provided.)

*Did this insertion attempt result in a successful central line placement?

Y

N

Custom Fields

Label

Label

_________________________

____/____/_____

_______________________

____/____/_____

_________________________

______________

_______________________

______________

_________________________

______________

_______________________

______________

_________________________

______________

_______________________

______________

_________________________

______________

_______________________

______________

_________________________

______________

_______________________

______________

_________________________

______________

_______________________

______________


Comments









































File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File Title57.125
SubjectNHSN OMB Forms 2020
AuthorCDC/NCZEID/DHQP
File Modified0000-00-00
File Created2024-09-05

© 2024 OMB.report | Privacy Policy